El año pasado, Sonoma Pharmaceuticals Inc generó 17.68M USD en su segmento con mejor rendimiento, Human Care. Europe realizó la mayor aportación, representando 6.90M USD el año pasado. Para el último trimestre, Sonoma Pharmaceuticals Inc reportó unos ingresos de 5.97M USD para el periodo finalizado el 2026-06-30, procedentes del segmento con mejor rendimiento, Human Care. United States aportó los mayores ingresos, alcanzando los 2.43M USD.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Human Care

Animal Care

Service and Royalty

Service

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Human Care

17.68M(90.54%)

12.08M(84.54%)

10.11M(79.39%)

9.43M(71.02%)

9.01M(71.35%)

15.32M(82.22%)

15.69M(87.49%)

15.91M(83.88%)

Animal Care

1.85M(9.46%)

1.65M(11.57%)

2.20M(17.30%)

2.50M(18.84%)

3.17M(25.10%)

3.20M(17.18%)

2.09M(11.66%)

1.97M(10.38%)

Service and Royalty

--(--)

556.00K(3.89%)

422.00K(3.31%)

1.35M(10.14%)

449.00K(3.56%)

--(--)

Service

--(--)

112.00K(0.60%)

151.00K(0.84%)

1.09M(5.74%)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Europe

United States

Asia

Latin America

Rest of the world

Europe

Asia

Europe and Rest of the World

Service Revenues

Product license fees and royalties

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

Europe

6.90M(35.35%)

--(--)

United States

5.67M(29.05%)

2.61M(18.27%)

3.06M(24.01%)

3.43M(25.83%)

3.81M(30.15%)

5.42M(29.09%)

7.99M(44.57%)

9.04M(47.65%)

8.37M(53.45%)

6.58M(51.31%)

4.37M(31.17%)

1.98M(15.22%)

1.41M(11.05%)

6.84M(44.28%)

4.72M(37.01%)

Asia

2.90M(14.85%)

--(--)

Latin America

2.37M(12.15%)

2.96M(20.73%)

1.73M(13.55%)

2.38M(17.96%)

2.10M(16.59%)

5.98M(32.08%)

3.77M(21.05%)

3.96M(20.89%)

3.01M(19.20%)

1.30M(10.13%)

4.96M(35.41%)

5.05M(38.88%)

3.76M(29.54%)

5.89M(38.09%)

5.19M(40.73%)

Rest of the world

1.68M(8.59%)

875.00K(6.12%)

872.00K(6.85%)

959.00K(7.23%)

--(--)

Europe

--(--)

5.52M(38.65%)

4.78M(37.54%)

4.05M(30.52%)

--(--)

Asia

--(--)

2.32M(16.22%)

2.30M(18.04%)

2.45M(18.47%)

--(--)

Europe and Rest of the World

--(--)

6.73M(53.26%)

7.23M(38.83%)

6.16M(34.38%)

4.88M(25.72%)

4.28M(27.35%)

4.08M(31.80%)

3.71M(26.43%)

2.91M(22.38%)

2.05M(16.08%)

1.85M(12.00%)

1.95M(15.28%)

Service Revenues

--(--)

1.09M(5.74%)

--(--)

868.00K(6.77%)

981.00K(7.00%)

3.06M(23.52%)

5.51M(43.33%)

869.00K(5.62%)

891.00K(6.99%)

Product license fees and royalties

--(--)